BACKGROUND: Data are scarce regarding employment outcomes of survivors of childhood allogeneic hematopoietic cell transplantation (alloHCT) and the factors that affect their employment status. METHODS: By using the Center for International Blood and Marrow Transplant Research database, the authors studied employment outcomes of ≥1-year survivors of childhood alloHCT who were age ≥18 years at their most recent assessment (year of transplantation, 1985-2010 
INTRODUCTION
The use of allogeneic hematopoietic cell transplantation (alloHCT) as a curative option for both benign and malignant hematologic conditions has increased. 1 Survival after HCT has improved over the years, and, according to Majhail and colleagues, there will be approximately 500,000 transplantation survivors in the United States by the year 2030. 2 As survival rates continue to improve, our understanding of the spectrum of late effects in survivors also is increasing. In addition to increased risks for life-threatening late effects, such as subsequent neoplasms, immune dysregulation, infections, and cardiovascular sequelae, alloHCT also has a significant impact on morbidities, including psychological (emotional distress, depression, anxiety, post-traumatic stress, cognitive dysfunction), social-environmental (return to work, adherence to treatment), physical (pain, fatigue, sleep disturbance, sexual dysfunction), and health-behavior (risk behaviors, unhealthy diet, physical inactivity) aspects of survivors' lives. 3 Educational and vocational attainment after HCT are important indicators of survivors' social and economic well being, overall function, and health-related quality of life (QOL). 4, 5 Unemployment or work-related difficulties may have a significant impact on QOL, health care access, and adherence to medical management. 6, 7 Similarly, education has
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an impact on survivors' ability to find employment and obtain health insurance, and it influences their marital status. 8 Our knowledge regarding employment outcomes among HCT survivors comes from studies focusing on transplantation recipients as adults. 4, 7, 9, 10 It is difficult to extrapolate conclusions from those studies because of differences in study design, inclusion of both allogeneic and autologous transplantation survivors, and conflicting results. A few single-center studies have assessed the employment outcomes in adult survivors of childhood HCT and consistently have reported higher unemployment rates among survivors compared with the general population or sibling controls. 11, 12 Studies focusing on adult survivors of childhood cancer who did not receive alloHCT also have reported higher unemployment rates among survivors compared with controls. [13] [14] [15] To our knowledge, there are no multi-institutional or multi-national data reporting employment or educational outcomes of survivors of childhood alloHCT. We used data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) to 1) evaluate the employment status of adult (aged ≥18 years at the time of the study) survivors of childhood (aged <18 years at HCT) alloHCT; and to 2) identify predictors of post-HCT employment in this population. An exploratory objective of this study was to describe the unemployment rates in our cohort in relation to the national unemployment rates.
MATERIALS AND METHODS

Data Source
The CIBMTR is a research collaboration between the National Marrow Donor Program/Be The Match and the Medical College of Wisconsin. More than 450 transplantation centers (TCs) worldwide contribute detailed data prospectively on consecutive transplantations to the CIBMTR. Compliance and accuracy of data reported to the CIBMTR are monitored by on-site audits. All patients are followed longitudinally until death or loss to follow-up. Patients and/or guardian(s) provide written informed consent for data submission and research participation. The study was conducted in accordance with the Declaration of Helsinki. The Institutional Review Board of the National Marrow Donor Program approved this study.
Patient Eligibility
The derivation of the study population is depicted in Figure 1 . We included patients who underwent their first alloHCT in childhood (aged <18 years at HCT) for any malignant or nonmalignant conditions between January 1, 1985, and December 31, 2010, and were reported to the CIBMTR. Patients were excluded if their TC had a 5-year completeness of follow-up <80%. Patients who survived alloHCT for at least 1 year and were aged ≥18 (employment-eligible age) at the time of the study were included (n = 5727). Patients who had missing employment information at all time points after HCT (n = 2862) and had a twin/syngeneic donor (n = 21) were excluded. Our final study population consisted of 2844 patients.
Employment Status
The CIBMTR database was used to abstract patientrelated, disease-related, and transplantation-related data and survivors' employment data. The specific question regarding work status on the post-HCT data forms was: "What is the recipient's current or most recent work status during the reporting period?" The answer choices were the following: full-time, part-time, unemployed, medical disability, retired, recipient aged <16 years, or unknown. Information regarding survivors' student status was obtained from another question asking to specify the category which best described the recipient's current occupation. "Student" was the answer choice of interest.
Definitions and Statistical Analysis
Descriptive statistics were presented for the patient-related, disease-related, and transplantation-related variables. Chi-square tests, Wilcoxon rank-sum tests, and Satterthwaite t tests were used to compare US and international survivors' baseline characteristics. To describe post-HCT employment status, survivors were divided into 6 categories: full-time work, part-time work, unemployed, retired, medical disability, and students. For convenience and because of the relatively young survivor cohort, students were described as a separate employment category regardless of their response to the work status question. Frequencies of employment status categories were provided according to survivors' attained ages based on the age distribution at survival, grouped as 18 to 22, 23 to 27, and 28 to 32 years and according to the TC location (United States and International) to account for the multinational nature of our study population. For the exploratory objective, a descriptive comparison of the unemployment rates of survivors with the US and international general populations was performed using unemployment data from the World Bank' prophylaxis (ex-vivo T-cell depletion/CD34 selection vs calcineurin inhibitors [CNI] with or without others vs others), acute GVHD, chronic GVHD, disease relapse or progression, and subsequent neoplasm at any time after alloHCT. We did not include the year of transplantation as a variable in the model because the age at transplantation, the choice of donor type/graft source, and conditioning intensity/receipt of TBI were highly correlated with the era of transplantation (eg, the use of unrelated donor type increased with increasing year of transplantation). The primary outcome was employment status at age ≥18 years (employment-eligible age); the first indication of being employed (full-time/part-time work or student) at age ≥18 years was considered an event. Students were considered employed for the convenience of analysis. Patients were considered unemployed if they never reported being in full-time/part-time work or being a student at any time point at age ≥18 years. The time to event was calculated from the time of alloHCT to the time when the first employment status at age ≥18 years was reported. Unemployed patients were censored at the end of their follow-up or death. To adjust for multiple comparisons, P values < .01 were considered statistically significant. The SAS statistical software package (version 9.4; SAS Institute Inc, Cary, NC) was used for all analyses.
RESULTS
Baseline Characteristics
Baseline characteristics of the patient population are described in Table 1 . Forty-eight percent of patients underwent transplantation in US TCs. The remaining population underwent transplantation in Europe (18%), Asia (17%), South America (7%), North America (5%), and Australia/New Zealand (5%). Baseline characteristics were compared between US and international survivors (Supporting Table 1 ). In addition, baseline characteristics of the study population (n = 2844) were compared with the survivors, excluded due to missing employment information at all time points after HCT (n = 2862), and no significant differences were noted (data not shown). 
Post-HCT Complications
The median follow-up was 11 years (range, 1.1-27.9 years). The overall incidence of acute and chronic GVHD was 49% and 37%, respectively, with a median development time interval of <1 month (range, from <1 to 184 months) and 5 months (range, from <1 to 190 months), respectively. Disease relapse or progression was noted in 9% of patients at a median interval of 23 months (range, from <1 to 241 months); and development of subsequent neoplasms and lymphoproliferative or myeloproliferative disorders was observed in 7% of patients at a median interval of 113 months (range, 1-268 months).
Post-AlloHCT Employment Rate
The rates of working status (combined full-time and part-time) increased from 7.3% in the group ages 18 to 22 years, to 45.5% in the group ages 23 to 27 years, and to 72.7% in the group ages 28 to 32 years in US survivors and from 3.7%, to 20.6%, and to 21%, respectively, in the international survivors (Fig. 2) . 
Predictors of Post-HCT Employment
A multivariable analysis assessing the predictors of post-HCT employment (in full-time/part-time work or students aged ≥18 years) revealed that, compared with survivors who underwent transplantation at international TCs, those who underwent transplantation at US TCs had a higher likelihood of being employed post-alloHCT Sex, race/ethnicity, and receipt of ATG/alemtuzumab were not associated with post-HCT employment status. None of the post-HCT complications we studied were associated significantly with post-HCT employment status.
DISCUSSION
To our knowledge, this is the only multi-institutional and multinational study assessing the employment status of survivors of childhood alloHCT. With increasing attained age after 18 years, the percentage of students decreased, as expected, and the percentage of survivors in full-time and part-time work increased. However, unemployment rates were persistently high at all studied attained ages after HCT, even at ages 28 to 32 years (14% in US survivors, 68% in international survivors).
The current results are consistent with previous smaller studies focusing on employment outcomes of childhood HCT survivors. Lof and colleagues investigated the employment status of patients who had survived for at least 5 years after alloHCT performed in childhood (at ages 1-16 years) at a single center in Sweden. 11 Those authors noted that these survivors (n = 51) had a lower level of post-HCT employment compared with the general population in Sweden and were more likely to have a disability pension. That study also demonstrated that 43% of HCT survivors were in the poverty risk zone compared with 6% of the general Swedish population. There was no significant difference between the numbers of survivors who were students compared with the general population. Another single-center, cross-sectional survey assessed the QOL of adult survivors of pediatric alloHCT and autologous HCT (n = 214) compared with a control population comprised of age-matched and sex-matched siblings or friends of survivors. 12 At the time of assessment, 82% of survivors were in full-time work or school or were working as full-time homemakers; however, the percentage was still significantly lower than the 92% in the control group (P = .001). Family financial support more commonly was needed by survivors compared with controls (15% vs 6%; P = .002).
Information regarding the factors that influence post-HCT employment or student status was lacking in these studies. While studying the predictors of employment, we observed that certain subgroups (eg, younger age at HCT, receipt of MAC with TBI, and international survivors) had a lower likelihood of being employed post-HCT, which is intriguing. Previous studies focusing on employment outcomes in adult survivors of childhood cancer who did not undergo HCT also demonstrated that younger age at diagnosis was associated with a decreased likelihood of being employed. Frobisher and colleagues studied the employment and occupational status of pediatric cancer survivors using the British Childhood Cancer Survivorship Study. 13 Compared with the general population, survivors were less likely to be employed. An increase in age at diagnosis was significantly associated with an increased likelihood of being employed. Trends of employed and student survivors were similar to those reported by our study. Pang and colleagues used data from the Childhood Cancer Survivor Study and demonstrated that survivors who were diagnosed with cancer between birth to age 3 years were at significantly higher risk of having never been employed compared with those who were older at the time of diagnosis. 15 Similar findings were noted in another cancer survivorship study, in which the mean age of the survivor cohort was 26 years at the time of the study, and survivors who were >30 years from the diagnosis were 1.89 times more likely to be unemployed compared with survivors who were ≤20 years from diagnosis.
14 On the basis of the results from these studies, we hypothesize that patients who undergo transplantation at a younger age are at greater risk for neurocognitive complications after HCT, as indicated in previous literature, 16 leading to academic and employment related-difficulties.
Radiation exposure, particularly TBI when used in the MAC setting, also has been postulated as neurotoxic and a cause of post-HCT neurocognitive abnormalities. 16 Smedler et al reported that patients who received TBI between ages 3 and 11 years had worse perceptual and fine motor abilities compared with their sibling donors. 17 These survivors were noted to have verbal reasoning difficulties even at 10 years post-HCT. In addition, TBI has a known association with debilitating long-term complications, such as endocrinopathies and end-organ damage. 18 Similarly, the studies focused on cancer survivors have consistently demonstrated negative effects of radiation, especially cranial radiotherapy, on employment outcomes. [13] [14] [15] It also has been reported that cranial radiation affects educational outcomes in long-term survivors of childhood cancer. 19 These findings may explain the significantly lower likelihood of employment noted in our study among survivors who received TBI at myeloablative doses.
Our findings of a lower likelihood of employment among survivors who underwent transplantation from a related donor using a BM graft source and received TBI in a conditioning regimen are likely reflective of the era of transplantation. Historically, patients underwent transplantation mainly using a human leukemic antigen (HLA)-identical sibling as their donor choice. Since the early 2000s, there have been significant advances in transplantation practice, including better donor availability and high-resolution HLA typing. In recent years, the numbers of transplantations using unrelated donors have significantly increased. 20 As the long-term toxicity profile of TBI has become evident, nonirradiation conditioning regimens have been used increasingly in the pediatric population over the last decade. Because most patients in our study population (75%) underwent transplantation before 2005, we may not appreciate the impact of changes in transplantation technology. It will be interesting to determine whether these findings remain the same in the future. In our current study, none of the assessed post-HCT complications (acute or chronic GVHD, relapse/progression, or subsequent neoplasm) were associated with post-HCT employment status.
In our study, patients who underwent transplantation at US TCs were more likely to be employed compared with those who underwent transplantation at international TCs. The US and international survivor cohorts differed in terms of their clinical characteristics; however, differences in the likelihood of employment persisted even after adjusting for these variables. Lower unemployment among the US survivors could be explained by the reality that individuals in the United States have to maintain employment to obtain health insurance. The health coverage difficulties faced by patients with pre-existing/chronic health conditions in the United States are well known. A previous study indicated that survivors of childhood cancer in the United States avoid job changes because they fear losing their health insurance and suffer from "job lock." 21 In that study, a high prevalence of job lock was observed among survivors who had a history of insurance denial and had difficulties paying medical bills. In contrast, the higher unemployment rates noted among survivors of international countries could be caused by the provision of national health coverage that does not rely on employer-based insurance. For example, in a recent study published by Tichelli et al, significantly higher percentages of both alloHCT and autologous HCT survivors in Switzerland reportedly were receiving disability pensions compared with the general Swiss population. 10 Similar findings were reported by Harder et al, who observed that 40% of Dutch HCT survivors were still receiving complementary sickness or unemployment insurance benefits at a median of 3.7 years post-HCT. 22 Caution should be exercised when interpreting the results of our current study comparing US versus international data, because we combined all other countries except the United States in the international category without accounting for their economic indicators, such as gross per capita income, health care system setup, health expenditure per capita, and the Human Development Index.
The current study has several limitations. CIBMTR data are collected by data managers through chart abstraction, and not by direct patient report. Therefore, details are lacking with regard to causes or duration of unemployment, survivors' educational attainment, and survivors' functional status. We also were unable to address the potential problem of underemployment in the study population. In our study, several patients were excluded because employment-related post-HCT data were not available. Although there was no significant difference between included and excluded patients based on baseline characteristics, other sources of post-HCT bias cannot be excluded. Because we lacked an age-matched, sex-matched, and race-matched control population, we were unable to make a statistical comparison of the unemployment rates noted in our study. Furthermore, the unequal duration of follow-up of survivors after age 18 years could have had an impact on differences in the likelihood of employment post-HCT. For convenience, survivors who were reported as students were included in the employed category for our analyses.
Conclusion
In conclusion, we observed that young adult survivors of childhood alloHCT had high unemployment rates at all studied attained ages after HCT. The likelihood of post-HCT employment (full-time/part-time work or student) was influenced by the era of transplantation. Patients who underwent transplantation at a younger age, those who had a poor performance score before HCT, those who received transplantation with a related donor and BM graft source, and those who received MAC that included TBI had a lower likelihood of employment.
Future Directions
With the growing numbers of alloHCT survivors, the high unemployment rates observed in our study, in turn, may significantly affect economic concerns as well as health care access. The current findings call for routine screening practices to avoid education-related or vocation-related difficulties for survivors. These findings also set the stage for future studies assessing the causes of unemployment in long-term survivors and the relation between employment outcomes and QOL. On the basis of these results, we anticipate the development of future clinical trials to change modifiable risk factors, such as avoiding the use of TBI at myeloablative doses (especially in younger age patients) and promoting the use of reduced-intensity/nonmyeloablative conditioning regimens whenever possible. In the future, we hope that strategies will be developed to increase survivors' likelihood of successfully returning to work and to integrate QOL and employment status as important treatment outcomes, along with overall survival and disease-free survival, in transplantation practice.
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